Kofeina jej zalety i działanie niepożądane

• Autorzy: Tomaszewski M. , Tomaszewska M. , Olchowik G.

Warianty tytułu

EN

Coffeine-its adventages and side effects

• Języki publikacji: PL EN

Abstrakty

PL

Kofeina jest szeroko rozpowszechniona w przemyśle spożywczym Obecna w produktach energetyzujących, doskonale sprawdza się w sytuacjach wymagających zwiększonej koncentracji. Będąca składnikiem kawy, czy herbaty jest powszechnym napojem spożywanym przez ogół społeczeństwa. Jednak nie można zapominać, że regularne przyjmowanie tej substancji, może prowadzić do pojawienia się szeregu działań ubocznych ze strony układu nerwowego, naczyniowo-sercowego czy rozrodczego. Artykuł zawiera aktualny stan wiedzy na temat właściwości kofeiny, możliwości jej zastosowania, z uwzględnieniem niekorzystnego jej wpływu na organizm człowieka.

EN

Caffeine is omnipresent in the food industry. It can be found in energizing products and it works best in situations which demand an increased concentration. As a coffee or tea ingredient it is widespread beverage consumed by the majority of the society. Nevertheless, we should remember that regular consumption of this substance may lead to several side effects of the nervous, cardio-vascular and reproductive systems. The article contains current state of knowledge on the features of caffeine, possibilities of its application including its harmful impact on the human body.

Słowa kluczowe

PL

zywienie czlowieka; kofeina; spozycie zywnosci; dzialanie mobilizujace; zdrowie czlowieka; przedawkowanie kofeiny; zagrozenia zdrowia; uklad nerwowy; uklad naczyniowo-sercowy; uklad rozrodczy

• Wydawca: -
• Czasopismo: Człowiek i Zdrowie
• Rocznik: 2013
• Tom: 07
• Numer: 3
• Opis fizyczny: s.47-63,tab.,bibliogr.

Twórcy

autor

Tomaszewski M.

• Katedra i Zakład Anatomii Prawidłowej Człowieka, Uniwersytet Medyczny w Lublinie, Al.Racławickie 1, 20-059 Lublin
• Instytut Zdrowia, Państwowa Szkoła Wyższa im.Papieża Jana Pawła II w Białej Podlaskiej, Biała Podlaska

autor

Tomaszewska M.

• I Zakład Radiologii Lekarskiej, Uniwersytet Medyczny w Lublinie, Lublin

autor

Olchowik G.

• Instytut Zdrowia, Państwowa Szkoła Wyższa im.Papieża Jana Pawła II w Białej Podlaskiej, Biała Podlaska
• Katedra i Zakład Biofizyki, Uniwersytet Medyczny w Lublinie, Lublin

Bibliografia

• 1. Arnaud M.J. (1984). Products of metabolism of caffeine. W: Dews P.B. (Red). Caffeine. Springer Verlag. Berlin. 3 – 38.
• 2. Arnaud M.J. (1999). Caffeine: chemistry and physiological effects. in: Encyclopedia of Human Nutrition. Sadler M.J., Stain J.J., Caballero B. (Red). Academic Press. San Diego. 206 – 214.
• 3. Barone J.J., Roberts H. (1996). Caffeine consumption. Food Chem Toxicol. 34, 119 – 129.
• 4. Benowitz N.L. (1990). Clinical pharmacology of caffeine. Annu Rev Med. 41, 277 – 288.
• 5. Berger A. 1988. Effects of caffeine consumption on pregnancy outcome. A review. J Reprod Med. 33, 945 – 956.
• 6. Bienvenu T., Pons G., Rey E. Richard M.O., d’Athis P., Olive G. (1990). Effect of hypophysectomy on caffeine elimination in rats. Fundam Clin Pharmacol. 4, 393 – 399.
• 7. Bonati M., Latini R., Galietti F., Young J.F., Tognoni G., Garattini S. (1982). Caffeine disposition after oral doses. Clin Pharmacol Ther. 32, 98 – 106.
• 8. Bounds W., Skinner J., Carruth B.R., Ziegler P. (2005). The relationship of diet ary and life style factors to bone mineral indexes in children. J Am Diet Assoc. 105, 735-741.
• 9. Burdan F. (2000). Teratogenic and embriotoxic effects of caffeine: facts and hypoteses. Pol Merkur Lekarski. 9, 726 – 728.
• 10. Burg A.W. (1975). Physiological disposition of caffeine. Drug Metab Rev. 4, 199 – 228.
• 11. Chen X., Whitford G.M. (1999). Effects of caffeine on 􀏐luoride, calcium and phosphorus metabolizm and calci- field tissues in the rat. Arch Oral Biol. 44, 33-39.
• 12. Christian M.S., Brent R.L. (2001). Teratogen update: Evaluation of the reproductive and developmental risks of caffeine. Teratology. 64, 51 – 78.
• 13. Conlisk J.A., Galuska A.D. (2000). Is caffeine associated with bone mineral den sity in Young adult women? Prev Med. 31, 562-568.
• 14. Cornelis M.C. i wsp. (2006). Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 295, 1135 – 1141.
• 15. Cornelis MC, El-Sohemy A. (2007). Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol. 18, 1, 13-9.
• 16. Countries by coffee consumption per capita. World Resource Institute. (2003).
• 17. Davis J.M., Zhao Z. i wsp. (2003). Central nervous system effects of caffeine and adenosine on fatigue. Am J Physiol Regul Integr Comp Physiol. 284; 399 – 404.
• 18. Dworzański W., Burdan F., Potembska E., Tomaszewski M., Tomaszewska M., Olchowik G. (2010). Kofeina a rozwój osteoporozy. Zdr Publ. 120, 1, 93-96.
• 19. Fisone G., Borkvist A., Usiello A. (2004). Caffeine as a psychomotor stymulant: mechanizm of action. CMLS, Cell. Mol. Life Sci. 61; 857 – 872.
• 20. Gao H, Zhang Z, Wan X. (2012). In􀏐luences of charcoal and bamboo charcoal amendment on soil-􀏐luoride fractions and bioaccumulation of 􀏐luoride in tea plants. Environ Geochem Health. 2012 May 13. (Epub ahead of print)
• 21. Garattini S., Bonati M., Latini R. (1979). Studies on the kinetics and metabolism of caffeine. W: Proceedings of first international caffeine committee workshop. Honolulu. Hawaii.
• 22. Garattini S., Bonati M., Latini R. (1980). Studies on the kinetics and metabolism of caffeine. W: Proceedings of third international caffeine committee workshop. Hunt Valley. Maryland.
• 23. Graham H.N. (1984). Tea: the plant and its manufacture, chemistry and consumption of the beverage. W: Spiller G.A. (Red). Progress in clinical and biological research. Tom 159. The methylxanthine beverages and foods: chemistry, consumption and health effects. Alan R Liss Press, New York. 29 – 74.
• 24. Griggs G.G., Freeman R.K., Yaffe S.J. (1998). Drugs in pregnency and Lactation. William and Wilkins. Baltimore.
• 25. Happonen P., Voutilainen S., Tuomainen T.P., Salonen J. T. (2006). Catechol-o-methyltransferase gene polymorphismmodifies the effect of coffee intake on incidence of acute coronary events. PLoS ONE. 1, e117.
• 26. Harris S.S., Dawson-Hughes B. (1994). Caffeine and bone loss in health postmenopausal women. Am J Clin Nutr. 60, 573-578.
• 27. Hasling C., Sondergaard K., Charles P., Mosekilde L. (1992). Calcium metabolizm in postmenopausal osteoporotic women is determinated by diet ary calcium and coffee intake. J Nutr. 122, 1119-1126.
• 28. Heaney R.P. (2002). Effects of caffeine on bone and calcium economy. Food Chem Toxicol. 40, 1263-1270.
• 29. Hernandez-Avila M., Coldits G.A., Stampfer M.J., Rosner B., Speizer F., Willett W.C. (1991). Caffeine, moderate alkohol intake, and risk of fractures of the hip and forearm in Middle-aged women. Am J Clin Nutr. 54, 157-163.
• 30. Index Leków MP (online) dostęp: http://www.mp.pl/leki/. Kofeina jej zalety i działanie niepożądane Człowiek i Zdrowie 2013, tom VII, nr 3 - 54 -
• 31. Keijzers G.B., De Galan B. E., Track C. J., Smits P. (2002). Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 25:364–369.
• 32. Kerrigan S., Lindsey T. (2005). Fatal caffeine overdose: Two case reports. Forensic Sci Int. 153, 67 – 69.
• 33. Kostowski W. (2008). Farmakologia – podstawy farmakoterapii. Wydawnictwo Lekarskie PZWL, Warszawa.
• 34. Kozłowski S., Rewerski W. (1980). Doping. PZWL. Warszawa.
• 35. Latini R., Bonati M., Castelli D., Garattini S. (1978). Dose – dependent kinetics of caffeine in rats. Toxicol Lett. 2, 267 – 270.
• 36. Lloyd T., Johnson-Rollings N., Eggli D., Kieselhorst K., Mauger E.A. (1998). Dietary caffeine intake is not correlated with adolescent bone gain. J Am Coll Nutr. 17, 454-457
• 37. Lopez-Garcia E. i wsp. (2006). Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 113, 2045 – 2053.
• 38. MacKenzie T., Comi R., Sluss P., Kesari R., Manwar S., Kom J., Larson R., Baron J.A. (2007). Metabolic and hormonal effects of caffeine randomized, double – blind, placebo – controlled crossover trial. Metab Clin Exp. 56, 1694 – 1698.
• 39. Meyer H.E., Pedersen J.I., Loken E.B., Tverdal A. (1997). Dietary factors and the incidence of hip fracture in Middle-aged Norwegians. A prospective study. Am J Epidemiol. 145, 117-123.
• 40. Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE. (2008). Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr. 87, 5, 1254-61.
• 41. Narod S.A., DeSanjose S., Victora C. (1991). Caffeine during pregnancy: a reproductive hazard? Am J Obstet Gynecol. 164, 1109 – 1114.
• 42. Nawrot P., Jordan S., Eastwood J., Hugenholtz A., Feeley M. (2003). Effects of caffeine on human health. Food Addit Contam. 20, 1 – 30.
• 43. Nehling A. (1999). Are we dependent upon coffee and caffeine? A review on human and Animals data. Neurosci Biobehav Rev. 23, 563 – 676.
• 44. Neims A.H., Von Borstel R.W. (1983). Caffeine: metabolism and biochemical mechanisms of action. W: Wurtman R.J., Wurtman J.J. (Red). Nutrition and the brain. Tom 6. Raven Press, New York. 1-30.
• 45. Nishimura H, Nakai K. (1960). Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Med. 104, 140 – 142.
• 46. Nolen G.A. (1989). The developmental toxicology of caffeine. W: Kalter H. (Red) Issues and reviews in teratology. Tom 4. Plenum Press, New York. 305-350.
• 47. Olchowik G., Chadaj-Polberg E., Tomaszewski M., Polberg M., Tomaszewska M. (2011). The in􀏐luence of caffeine on the biomechanical properties of bone tissue during pregnancy in a population of rats. Folia Histochemica et Cytobiologica. 49, 3, 504-511.
• 48. Pereira M. A. i wsp. (2006). Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch. Intern. Med. 166, 1311 – 1316.
• 49. PKL Pharmindex kompendium leków. Medi Media International, Warszawa. (2007).
• 50. Pollard I., Jabbour H., Mehrabani P.A. (1987). Effects of caffeine administered during pregnancy on fetal development and subsequent function in the adult rat: prolonged effects on the second generation. J Toxicol Environ Health. 22, 1 – 16.
• 51. Prescott L. (1989). Analgesis. Practitioner. 200, 84 – 92.
• 52. Rapturi P.B., Gallagher J.C., Kinyamu H.K., Ryschon K.L. (2001). Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 74, 694-700.
• 53. Rapturi P.B., Gallagher J.C., Nawaz Z. (2007). Caffeine decreases vitamin D receptor protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase activity in human osteoblast cells. J Steroid Biochem Mol Biol. 103, 368-371.
• 54. Ribeiro-Alves M.A., Trugo L.C., Donangelo C.M. (2003). Use of oral contraceptives blunts the calciuretic effects of caffeine in young adult women. J Nutr. 393-398.
• 55. Shalleck J. (1981). Tea. Vicing Press, New York.
• 56. Shardein J. (1993). Chemically induced birth defects. WYd. 2. Marcel Dekker, New York.
• 57. Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, Abbate R, Gensini GF. (2007). Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 17, 3:209-23.
• 58. Spiller G.A. (1984). The chemical components of coffee. W: Spiller G.A. (Red) Progress in clinical and biological research. Tom 158. The methlyxanthine beverages and foods: chemistry, consumption and health effects. Alan R Liss, New York. 1 – 47.\ Kofeina jej zalety i działanie niepożądane Człowiek i Zdrowie 2013, tom VII, nr 3 - 55 -
• 59. Stavric B., Gilbert S.G. (1990). Caffeine metabolism: a problem in extrapolating results from animal studies to humans. Acta Pharm Jugosl. 40, 475 – 489.
• 60. Tsuang Y.H., Sun J.S., Chen L.T., Sun S.C.K., Chen S.C. (2006). Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosis. Journal of Orthopaedic Surgery and Research 1, 7, 1749-1799.
• 61. van Dam R.M. i wsp. (2005). Coffee consuptionand risk of type 2 diabetes: a systemaitc review. JAMA. 294; 97 – 104.
• 62. Yang D.J., Hwang L.S., Lin J.T. (2007). Effects of different steeping methods and storag on caffeine, catechins and gallic acid in bag tea infusions. J Chromatogr A. 1139.
• 63. Zancheta R., Possi A.P., Planeta C.S., Marin M.T. (2012). Repeated administration of caffeine induces either sensitization or tolerance of locomotor stimulation depending on the environmental context. Pharmacol Rep. 64, 1, 70-7